. 2021 Jun 28;13(6):e15986. doi: 10.7759/cureus.15986
Copyright © 2021, Plant et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Figure 3. Creatinine trend in relation to adalimumab.
